Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Dr. Lal PathLabs Limited
  6. Summary
    539524   INE600L01024

DR. LAL PATHLABS LIMITED

(539524)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Bombay Stock Exchange
09/09/2021 09/13/2021 09/14/2021 09/15/2021 09/16/2021 Date
4116.1 4166.75 4142.85 4209 4092.85 Last
6995 5093 1923 11453 10132 Volume
+0.76% +1.23% -0.57% +1.60% -2.76% Change
Estimated financial data (e)
Sales 2022 20 066 M 273 M 273 M
Net income 2022 4 021 M 54,7 M 54,7 M
Net cash position 2022 11 566 M 157 M 157 M
P/E ratio 2022 84,6x
Yield 2022 0,45%
Sales 2023 21 525 M 293 M 293 M
Net income 2023 4 308 M 58,6 M 58,6 M
Net cash position 2023 14 182 M 193 M 193 M
P/E ratio 2023 77,4x
Yield 2023 0,48%
Capitalization 338 B 4 595 M 4 597 M
EV / Sales 2022 16,3x
EV / Sales 2023 15,1x
Nbr of Employees 3 996
Free-Float 37,6%
More Financials
Company
Dr. Lal PathLabs Limited is engaged in providing diagnostic and related healthcare tests and services. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of Bio-chemistry, Hematology, Histopathology, Microbiology, Electrophoresis, Immuno-chemistry, Immunology, Virology, Cytology, other pathological and radiological investigations. The... 
More about the company
Ratings of Dr. Lal PathLabs Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about DR. LAL PATHLABS LIMITED
08/03DR LAL PATHLABS : Nomura Adjusts Dr. Lal Pathlabs' Price Target to 2,465 Indian ..
MT
08/02DR LAL PATHLABS : . Lal PhathLabs' Consolidated Profit Soars in Fiscal Q1
MT
07/30Dr. Lal Pathlabs Limited Declares Interim Dividend for the Financial Year 202..
CI
07/30Dr. Lal Pathlabs Limited Reports Earnings Results for the First Quarter Ended..
CI
07/29Dr. Lal PathLabs Limited Approves Dividend for the Financial Year Ended March..
CI
07/06Dr. Lal Pathlabs Limited to Declare Dividend for the Financial Year Ended Mar..
CI
06/18Suburban Diagnostics Reportedly in Sale Talks with Dr. Lal PathLabs, Metropol..
CI
05/24DR LAL PATHLABS : Nomura Adjusts Dr. Lal Pathlabs' Price Target to 2,345 Indian ..
MT
05/24DR LAL PATHLABS' : Consolidated Profit Jumps in Fiscal Q4
MT
05/21Dr. Lal Pathlabs Limited Recommends Final Dividend for the Year Ended March 3..
CI
04/14DR LAL PATHLABS : Nomura Downgrades Dr Lal Pathlabs to Reduce From Neutral, Adju..
MT
01/29Dr. Lal Pathlabs Limited Declares Second Interim Dividend for the Financial Y..
CI
01/29Dr. Lal Pathlabs Limited Reports Earnings Results for the Third Quarter Ended..
CI
2020Dr. Lal PathLabs Limited Declares an Interim Dividend for the Financial Year ..
CI
2020Dr. Lal Pathlabs Limited Reports Earnings Results for the Second Quarter Ende..
CI
More news
News in other languages on DR. LAL PATHLABS LIMITED

- No features available -

More news
Analyst Recommendations on DR. LAL PATHLABS LIMITED
More recommendations
Chart DR. LAL PATHLABS LIMITED
Duration : Period :
Dr. Lal PathLabs Limited Technical Analysis Chart | 539524 | INE600L01024 | MarketScreener
Technical analysis trends DR. LAL PATHLABS LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 19
Last Close Price 4 092,85 INR
Average target price 3 070,37 INR
Spread / Average Target -25,0%
EPS Revisions
Managers and Directors
Bharath Uppiliappan Chief Executive Officer
Ved Prakash Goel Chief Financial Officer
Arvind Lal Executive Chairman
Munender Soperna Chief Information Officer
Rajat Kalra Secretary, Compliance Officer & Head-Legal
Sector and Competitors